Mutation in Region III of the DNA Polymerase Gene Conferring Foscarnet Resistance in Cytomegalovirus Isolates from 3 Subjects Receiving Prolonged Antiviral Therapy

Three human immunodeficiency virus-infected subjects with progressive cytomegalovirus (CMV) retinitis despite prolonged antiviral therapy had buffy coat CMV isolates that were resistant to both ganciclovir and foscarnet. Genetic analysis of the resistant isolates showed that each contained a well-kn...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 178; no. 2; pp. 526 - 530
Main Authors Chou, Sunwen, Marousek, Gail, Parenti, David M., Gordon, Shelley M., LaVoy, Alison G., Ross, Jennifer G., Miner, Richard C., Drew, W. Lawrence
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.08.1998
University of Chicago Press
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Three human immunodeficiency virus-infected subjects with progressive cytomegalovirus (CMV) retinitis despite prolonged antiviral therapy had buffy coat CMV isolates that were resistant to both ganciclovir and foscarnet. Genetic analysis of the resistant isolates showed that each contained a well-known ganciclovir resistance mutation in the viral UL97 phosphotransferase sequence, as well as a mutation (Ala to Val at codon 809, V809) in conserved region III of the DNA polymerase (Pol) sequence. A segment of the Pol sequence from one of the clinical isolates was transferred to CMV laboratory strain AD169 by homologous recombination. The recombinant virus containing V809 showed 6.3-fold increased foscarnet resistance and 2.6-fold increased ganciclovir resistance. Occurrence of the V809 mutation in 3 unrelated cases suggests that it is a clinically significant viral genetic marker for foscarnet resistance and decreased susceptibility to ganciclovir.
Bibliography:istex:AF030FB7FD73FA31BDFD4D21BCB954EC97B61EB2
Presented in part: Infectious Diseases Society of America Annual Meeting, San Francisco, September 1997.
ark:/67375/HXZ-C50NFDFH-P
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Case Study-3
ObjectType-Article-1
ObjectType-Feature-4
ObjectType-Report-2
ISSN:0022-1899
1537-6613
DOI:10.1086/515648